Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Parniak

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|May 20, 2017
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral ActivitySanjeev Kumar V Vernekar, Jing Tang, Bulan Wu, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral DrugsAtsuko Hachiya, Aaron B Reeve, Bruno Marchand, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosineKaren A Kirby, Eleftherios Michailidis, Tracy L Fetterly, et al.
Retrovirology|June 27, 2013
Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdAEleftherios Michailidis, Emily M Ryan, Atsuko Hachiya, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptaseKaren A Kirby, Bruno Marchand, Yee Tsuey Ong, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
The Journal of Biological Chemistry|September 8, 2012
Biochemical mechanism of HIV-1 resistance to rilpivirineKamalendra Singh, Bruno Marchand, Devendra K Rai, et al.
ACS Chemical Biology|December 23, 2006
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel siteDaniel M Himmel, Stefan G Sarafianos, Sanjeewa Dharmasena, et al.
Viruses|October 28, 2023
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 SubtypesMaria E Cilento, Xin Wen, Aaron B Reeve, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|May 20, 2017
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral ActivitySanjeev Kumar V Vernekar, Jing Tang, Bulan Wu, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral DrugsAtsuko Hachiya, Aaron B Reeve, Bruno Marchand, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosineKaren A Kirby, Eleftherios Michailidis, Tracy L Fetterly, et al.
Retrovirology|June 27, 2013
Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdAEleftherios Michailidis, Emily M Ryan, Atsuko Hachiya, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptaseKaren A Kirby, Bruno Marchand, Yee Tsuey Ong, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
The Journal of Biological Chemistry|September 8, 2012
Biochemical mechanism of HIV-1 resistance to rilpivirineKamalendra Singh, Bruno Marchand, Devendra K Rai, et al.
ACS Chemical Biology|December 23, 2006
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel siteDaniel M Himmel, Stefan G Sarafianos, Sanjeewa Dharmasena, et al.
Viruses|October 28, 2023
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 SubtypesMaria E Cilento, Xin Wen, Aaron B Reeve, et al.
Pageof 9